(From Abstract) Despite vigorous CTL responses, HIV-1 infection usually leads to disease progression in the majority of infected individuals. The mechanisms responsible for viral persistence and failure of the cellular immune response remain mechanisms by which HIV-1 may elude the host cytolytic response, specifically: (a) the role of virologic factors in escaping recognition by CTL (sequence variation leading to nonrecognition and use of accessory genes to escape immune recognition), (b) the ability of CTL to suppress HIV-1 replication in various primary cell types (including non-lymphocytic cells susceptible to infection), and (c) the phenotype and function of HIV-1-specific CTL from bulk CD8+ cells in infected individuals. A previously established experimental system will be utilized for these studies. In general, acutely infected transformed CD4+ cell lines will cocultured with HLA-matched HIV-1 CTL clones. Manipulation of individual components of this experimental system will be employed to analyze specific factors that may affect the ability of CTL to suppress HIV-1 replication. Variation of the virus used for infection of the target cells will allow examination of virologic factors such as epitope mutations or function of accessory genes. Substitution of different primary cells as target cells will allow analysis of the susceptibility of various cell types to inhibition by CTL. Use of polyclonal CD8+ lymphocytes from infected individuals will allow evaluation of the inhibitory activity of uncloned CTL and functional comparison to CTL clones.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI043203-06
Application #
6510843
Study Section
AIDS and Related Research Study Section 1 (ARRA)
Program Officer
Plaeger, Susan F
Project Start
1998-04-01
Project End
2003-03-31
Budget Start
2002-04-01
Budget End
2003-03-31
Support Year
6
Fiscal Year
2002
Total Cost
$256,338
Indirect Cost
Name
University of California Los Angeles
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Ding, Ke; Zhang, Xing; Mrazek, Jan et al. (2018) Solution Structures of Engineered Vault Particles. Structure 26:619-626.e3
Balamurugan, Arumugam; Claiborne, Deon; Ng, Hwee L et al. (2017) HIV-1 Epitope Variability Is Associated with T Cell Receptor Repertoire Instability and Breadth. J Virol 91:
Babad, J; Mukherjee, G; Follenzi, A et al. (2015) Generation of ? cell-specific human cytotoxic T cells by lentiviral transduction and their survival in immunodeficient human leucocyte antigen-transgenic mice. Clin Exp Immunol 179:398-413
De La Cruz, Justin; Vollbrecht, Thomas; Frohnen, Patricia et al. (2014) Ineffectual targeting of HIV-1 Nef by cytotoxic T lymphocytes in acute infection results in no functional impairment or viremia reduction. J Virol 88:7881-92
Al-Mawsawi, Laith Q; Wu, Nicholas C; De La Cruz, Justin et al. (2014) Short communication: HIV-1 gag genetic variation in a single acutely infected participant defined by high-resolution deep sequencing. AIDS Res Hum Retroviruses 30:806-11
Wu, Nicholas C; De La Cruz, Justin; Al-Mawsawi, Laith Q et al. (2014) HIV-1 quasispecies delineation by tag linkage deep sequencing. PLoS One 9:e97505
Harris, D T; Badowski, M; Balamurugan, A et al. (2013) Long-term human immune system reconstitution in non-obese diabetic (NOD)-Rag (-)-? chain (-) (NRG) mice is similar but not identical to the original stem cell donor. Clin Exp Immunol 174:402-13
Bhattacharya, Debika; Lewis, Martha J; Lassmann, Britta et al. (2013) Combination of allele-specific detection techniques to quantify minority resistance variants in hepatitis B infection: a novel approach. J Virol Methods 190:34-40
Yeghiazarian, Lilit; Cumberland, William G; Yang, Otto O (2013) A stochastic multi-scale model of HIV-1 transmission for decision-making: application to a MSM population. PLoS One 8:e70578
Balamurugan, Arumugam; Ali, Ayub; Boucau, Julie et al. (2013) HIV-1 gag cytotoxic T lymphocyte epitopes vary in presentation kinetics relative to HLA class I downregulation. J Virol 87:8726-34

Showing the most recent 10 out of 52 publications